Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas. (Q54297439)

27 May 2018

title

Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas. (English)

1 reference

27 May 2018

6

Lydia Nakopoulou

1 reference

27 May 2018

author name string

Efthimia Souka

1

1 reference

27 May 2018

Evaggelos Alexiadis

2

1 reference

27 May 2018

Irini Theohari

3

1 reference

27 May 2018

Ioanna Giannopoulou

4

1 reference

27 May 2018

Christos Papadimitriou

5

1 reference

27 May 2018

publication date

1 October 2012

1 reference

27 May 2018

published in

Histopathology

1 reference

27 May 2018

volume

61

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

644-651

1 reference

27 May 2018

Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Oncogenic growth factor receptors: implications for signal transduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Histological grading of breast carcinomas: a study of interobserver agreement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Analysis of extended genomic rearrangements in oncological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Clinical value of epidermal growth factor receptor expression in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

Constitutive fragile sites and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04315.X

10.1111/J.1365-2559.2012.04315.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

22882128

1 reference

27 May 2018